COMT Inhibition for the Treatment of Parkinson's Disease: Introduction
COMT Inhibition for the Treatment of Parkinson's Disease: Articles
- COMT inhibitionA new treatment strategy for Parkinson's diseaseMatthias C. Kurth, Charles H. Adler
- Highlights of the North American and European experiencesChristopher G. Goetz
- Tolcapone in stable Parkinson's diseaseEfficacy and safety of long-term treatmentC. H. Waters, M. Kurth, P. Bailey, L. M. Shulman, P. LeWitt, E. Dorflinger, D. Deptula, S. Pedder, Tolcapone Stable Study Group
- Catechol-O-methyltransferase inhibition with tolcapone reduces the"wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsH. Baas, A. G. Beiske, J. Ghika, M. Jackson, W. H. Oertel, W. Poewe, G. Ransmayr
- Tolcapone improves motor function in parkinsonian patients with the"wearing-off" phenomenonA double-blind, placebo-controlled, multicenter trialA. H. Rajput, W. Martin, M. H. Saint-Hilaire, E. Dorflinger, S. Pedder
Advertisement
Popular on
Neurology

Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Advertisement